PBC

PBC (PBC) is a company in Vietnam's Health Care sector, listed on UPCOM. The stock last traded at 5,300 VND, little changed on the session, giving a market capitalization of 618.5 billion VND.

On valuation, PBC trades at a price-to-earnings ratio of 14.9 and a price-to-book of 0.5. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 3.1% points to weak profitability relative to the company's equity base, below the sector average of 11.5%. Trailing earnings per share stand at 348 VND.

Aveluro tracks 3 news items mentioning PBC, where recent coverage skews negative (67% of articles). The most recent catalyst was an insider trade event — "PNJ CEO buys 1 million shares; insider trades across MWG, SSI, VBB, NKG". Aveluro's composite model rates PBC 6.1/10 (Neutral), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Recent developments around PBC include 3 notable classified events. On Aug 23, 2026, a market event was reported: PNJ CEO Phan Quoc Cong bought 1 million shares, lifting his stake to 0.2% ahead of an extraordinary shareholder meeting. On Aug 19, 2026, a market event was reported: Pharbaco (PBC) CEO Nguyễn Đình Tuấn was fined nearly 524 million VND and banned from securities trading for 18 months after failing to report a purchase of 3.49 million shares on April 28, 2026. A recent a market event was reported: Pharbaco (PBC) CEO Nguyen Dinh Tuan was fined 523.7 million VND and suspended from securities trading for 18 months after failing to report a planned purchase of nearly 3.5 million PBC shares on April 28, 2026.

The overall tone of recent coverage is negative, with 2 of 3 events carrying bearish sentiment.